CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF PORTAL HYPERTENSION

Overview

Journal Acta Clin Croat

Specialty General Medicine

Date 2025 Feb 17

PMID 39959335

Authors

Ivica Grgurevic

Tajana Filipec Kanizaj

Hrvoje Ivekovic

Ivana Mikolasevic

Sandra Milic

Anna Mrzljak

Lucija Virovic Jukic

Ivan Balen

Tomislav Bokun

Petra Dinjar Kujundzic

Milos Lalovac

Maja Mijic

Nikola Sobocan

Sanja Stojsavljevic Shapeski

Irena Hrstic

Dinko Ladic

Zeljko Puljiz

Rajko Ostojic

Affiliations

Soon will be listed here.

Abstract

Liver diseases are currently the eleventh leading cause of global mortality, and cirrhosis holds the ninth position among the causes of death in Europe. The progression of cirrhosis gives rise to complications such as portal hypertension (PH), liver failure, and development of hepatocellular carcinoma. PH plays a pivotal role in the advancement of chronic liver disease and stands as an independent predictor of mortality in individuals with cirrhosis. Given the numerous updates in the classification, diagnosis, and treatment strategies for PH, the adoption of national guidelines has become imperative to enhance the care of this patient population. In the wake of Baveno VII consensus, as well as the recently published data, the working group of the Croatian Society of Gastroenterology drafted the guidelines that were discussed and agreed during 2023. Herein, we present a condensed version highlighting the key recommendations.

References

Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A . Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987; 7(1):122-8. DOI: 10.1002/hep.1840070124. View

Gluud L, Dam G, Les I, Marchesini G, Borre M, Aagaard N . Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017; 5:CD001939. PMC: 6481897. DOI: 10.1002/14651858.CD001939.pub4. View

Grgurevic I, Madir A, Trkulja V, Bozin T, Aralica G, Podrug K . Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography. Eur J Clin Invest. 2022; 52(6):e13750. DOI: 10.1111/eci.13750. View

Biggins S, Angeli P, Garcia-Tsao G, Gines P, Ling S, Nadim M . Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021; 74(2):1014-1048. DOI: 10.1002/hep.31884. View

Pose E, Napoleone L, Amin A, Campion D, Jimenez C, Piano S . Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Gastroenterol Hepatol. 2019; 5(1):31-41. DOI: 10.1016/S2468-1253(19)30320-6. View

Patidar K, Thacker L, Wade J, Sterling R, Sanyal A, Siddiqui M . Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol. 2014; 109(11):1757-63. PMC: 4321782. DOI: 10.1038/ajg.2014.264. View

De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C . Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022; 76(4):959-974. PMC: 11090185. DOI: 10.1016/j.jhep.2021.12.022. View

Stefanescu H, Rusu C, Lupsor-Platon M, Nicoara Farcau O, Fischer P, Grigoras C . Liver Stiffness Assessed by Ultrasound Shear Wave Elastography from General Electric Accurately Predicts Clinically Significant Portal Hypertension in Patients with Advanced Chronic Liver Disease. Ultraschall Med. 2019; 41(5):526-533. DOI: 10.1055/a-0965-0745. View

Sharma B, Sharma P, Lunia M, Srivastava S, Goyal R, Sarin S . A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013; 108(9):1458-63. DOI: 10.1038/ajg.2013.219. View

10.

Trawale J, Paradis V, Rautou P, Francoz C, Escolano S, Sallee M . The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int. 2009; 30(5):725-32. DOI: 10.1111/j.1478-3231.2009.02182.x. View

11.

Rimola A, Garcia-Tsao G, Navasa M, Piddock L, Planas R, Bernard B . Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000; 32(1):142-53. DOI: 10.1016/s0168-8278(00)80201-9. View

12.

Lai J, Rahimi R, Verna E, Kappus M, Dunn M, McAdams-DeMarco M . Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019; 156(6):1675-1682. PMC: 6475483. DOI: 10.1053/j.gastro.2019.01.028. View

13.

Lee S, Saxinger L, Ma M, Prado V, Fernandez J, Kumar D . Bacterial infections in acute variceal hemorrhage despite antibiotics-a multicenter study of predictors and clinical impact. United European Gastroenterol J. 2017; 5(8):1090-1099. PMC: 5721982. DOI: 10.1177/2050640617704564. View

14.

de Souza A, La Mura V, Reverter E, Seijo S, Berzigotti A, Ashkenazi E . Patients whose first episode of bleeding occurs while taking a β-blocker have high long-term risks of rebleeding and death. Clin Gastroenterol Hepatol. 2012; 10(6):670-6. DOI: 10.1016/j.cgh.2012.02.011. View

15.

Brensing K, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H . Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut. 2000; 47(2):288-95. PMC: 1727992. DOI: 10.1136/gut.47.2.288. View

16.

Bairaktari E, Liamis G, Tsolas O, Elisaf M . Partially reversible renal tubular damage in patients with obstructive jaundice. Hepatology. 2001; 33(6):1365-9. DOI: 10.1053/jhep.2001.25089. View

17.

Sharma P, Sharma B . Disaccharides in the treatment of hepatic encephalopathy. Metab Brain Dis. 2013; 28(2):313-20. DOI: 10.1007/s11011-013-9392-4. View

18.

Durand F, Graupera I, Gines P, Olson J, Nadim M . Pathogenesis of Hepatorenal Syndrome: Implications for Therapy. Am J Kidney Dis. 2015; 67(2):318-28. DOI: 10.1053/j.ajkd.2015.09.013. View

19.

Zhang M, Wang G, Zhao L, Wu Z, Zhang W, Zhang C . Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG. Scand J Gastroenterol. 2016; 51(12):1502-1506. DOI: 10.1080/00365521.2016.1193218. View

20.

Fierbinteanu-Braticevici C, Tribus L, Peagu R, Petrisor A, Baicus C, Cretoiu D . Spleen Stiffness as Predictor of Esophageal Varices in Cirrhosis of Different Etiologies. Sci Rep. 2019; 9(1):16190. PMC: 6838194. DOI: 10.1038/s41598-019-52407-y. View